Ultrasound contrast enhancing agents in neurosonology: Principles, methods, future possibilities

Acta Neurologica Scandinavica

Volumn 102, Issue 1, 2000, Pages 1-10

  Droste, Dirk W ^a   Kaps, M ^a   Navabi, D G ^a   Ringelstein, E B ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cerebrovascular diseases; Echocontrast agents; Ultrasonics

Indexed keywords

CONTRAST MEDIUM; ECHOVIST; FS 069; PERFLUOROPENTANE; SHU 508; SONOVUE;

BRAIN ARTERIOVENOUS MALFORMATION; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; INTRACRANIAL ANEURYSM; OCCLUSIVE CEREBROVASCULAR DISEASE; REVIEW;

CAROTID ARTERY DISEASES; CAROTID ARTERY, INTERNAL; CEREBROVASCULAR DISORDERS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VERTEBROBASILAR INSUFFICIENCY;

EID: 0034123792     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.102001001.x     Document Type: Review

References (60)

1. 1. MARTIN PJ, EVANS DH, NAYLOR AR. Measurement of blood flow velocity in the basal cerebral circulation: advantages of transcranial color-coded sonography over conventional transcranial Doppler. J Clin Ultrasound 1995;23:21-6.
2. 2. BOGDAHN U, BECKER G, WINKER J, GREINER K, PEREZ J, MEURERS B. Transcranial color-coded real-time sonography in adults. Stroke 1990;21:1680-8.
3. 3. BAUMGARTNER RW, MATHIS J, STURZENEGGER M, MATTLE HP. A validation study on the intraobserver reproducibility of transcranial color-coded duplex sonography velocity measurements. Ultrasound Med Biol 1994;20:233-7.
4. 4. MARTIN PJ, EVANS DH, NAYLOR AR. Transcranial color-coded sonography of the basal cerebral circulation. Reference data from 115 volunteers. Stroke 1994;25:390-6.
5. 5. BAUMGARTNER RW, MATTLE HP, AASLID R, KAPS M. Transcranial color-coded duplex sonography in arterial cerebrovascular disease. Cerebrovasc Dis 1997;7:57-63.
6. 6. ROSENKRANZ K, ZENDEL W, LANGER R et al. Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles. Radiology 1993;187:439-43.
7. 7. GEBEL M, CASELITZ M, BOWEN-DAVIES PE, WEBER S. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 A (Levovist) for Doppler signal enhancement in the portal vascular system. Ultraschall in Med 1998;19:148-56.
8. 8. KAPS M, SEIDEL G, BOKOR D, MODRAU B. Safety and ultrasound enhancing potentials of a new sulfur hexafluoride containing agent in the cerebral circulation. 1998 (unpublished).
9. 9. CORREAS JM, QUAY S. EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids. Clin Radiol 1996;51(suppl 1):11-14.
10. 10. CORREAS JM, WORAH D, QUAY S. EchoGen phase 2 clinical trial: safety and efficacy of an ultrasound contrast agent. 1995 (abstract).
11. 11. MELANY ML, PLATT JF, AFONSO SA, TEEEEYSA, KOPECKY KK. Phase III multicenter clinical trial of a US contrast agent for use in diagnostic radiology. 1996:40 (abstract).
12. 12. GAHN G, ACKERMAN RH, CANDIA MR, BARRETT KM, LEV MH, HUANG AY. Ultrasound contrast enhancement with EchoGen in carotid diagnosis. Cerebrovasc Dis 1996;6(suppl 3):37 (abstract).
13. 13. SKYBA DM, CAMARANO G, GOODMAN NC, PRICE RJ, SKALAK TC, KAUL S. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. Am Coll Cardiol 1996;28:1292-300.
14. 14. FÜRST G, SITZER M, HOFER M, STEINMETZ H, HACKLÄNDER T, MÖDDER U. Kontrastmittelverstärkte farbkodierte Duplex-sonographie hochgradiger Karotisstenosen. Ultraschall Med 1995;16:140-4.
15. 15. GUTBERLET M, VENZ S, ZENDEL W, HOSTEN N, FELIX R. Do ultrasonic contrast agents artificially increase maximum Doppler shift? In vivo study of human common carotid arteries. J Ultrasound Med 1998;17:97-102.
16. 16. SITZER M, ROSE G, FÜRST G, SIEBLER M, STEINMETZ H. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis. J Neuroimaging 1997;7(suppl 1):22-5.
17. 17. NABAVI DG, DROSTE DW, SCHULTE-ALTEDORNEBURG G et al. Klinische Bedeutung der Echokontrastverstärkung in der neurovaskulären Diagnostik. Fortschr Neurol Psychiatr 1998;66:466-73.
18. 18. DROSTE DW, JÜRGENS R, NABAVI DG, SCHÜIERER G, WEBER S, RINCELSTEIN EB. Echocontrast-enhanced ultrasound of extracranial internal carotid artery high-grade stenosis and occlusion. Stroke 1999;30:2302-2306.
19. 19. HANKEY GJ, WARLOW C, SELLAR RJ. Cerebral angiographic risk in mild cerebrovascular disease. Stroke 1990;21:209-22.
20. 20. OTIS S, RUSCH M, BOYAJIAN R. Contrast-enhanced transcranial imaging. Results of an American phase-two study. Stroke 1995;26:203-9.
21. 21. SCHWARZ KQ, BECHER H, SCHIMPFKY C, VORWERK D, BOGDAHN U, SCHLIEF R. Doppler enhancement with SH U 508A in multiple vascular regions. Radiology 1994;193:195-201.
22. 22. RIES F, HONISCH C, LAMBERTZ M, SCHLIEF R. A transpulmonary contrast medium enhances the transcranial Doppler signal in humans. Stroke 1993;24:1903-9.
23. 23. BOGDAHN U, BECKER G, SCHLIEF R, REDDIG J, HASSEL W. Contrast-enhanced transcranial color-coded real-time sonography. Results of a phase-two study. Stroke 1993;24:676-84.
24. 24. KAPS M, SEIDEL G, BAUER T, BEHRMANN B. Imaging of the intracranial vertebrobasilar system using color-coded ultrasound. Stroke 1992;23:1577-82.
25. 25. KAPS M, SCHAFFER P, BELLER KD, SEIDEL G, BLIESATH H, WURST W. Phase I: transcranial echo contrast studies in healthy volunteers. Stroke 1995;26:2048-52.
26. 26. GOERTLER M, KROSS R, BAEUMER M et al. Diagnostic impact and prognostic relevance of early contrast-enhanced transcranial color-coded duplex sonography in acute stroke. Stroke 1998;29:955-62.
27. 27. NABAVI DG, DROSE DW, SCHULTE-ALTEDORNEBURG G et al. Diagnostic benefit of echocontrast-enhancement for the insufficient transtemporal bone window. J Neuroimaging 1999;9:102-7.
28. 28. DROSTE DW, NABAVI DG, KEMÉNY V et al. Echocontrast enhanced transcranial color-coded duplex offers improved visualization of the vertebrobasilar system in patients with bad examination conditions. Acta Neurol Scand 1998;98:193-9.
29. 29. NABAVI DG, DROSTE DW, KEMÉNY V, SCHULTE-ALTEDORNEBURG G, WEBER S, RINGELSTEIN EB. Potential and limitations of echocontrast-enhanced ultrasonography in acute stroke patients: a pilot study. Stroke 1998;29:949-54.
30. 30. BAUMGARTNER RW, ARNOLD M, GÖNNER F et al. Contrast-enhanced transcranial color-coded duplex sonography in ischemic cerebrovascular disease. Stroke 1997;28:2473-8.
31. 31. KAPS M, LINK A. Transcranial ultrasound monitoring during thrombolytic therapy. Am J Neuroradiology 1997;19:758-60.
32. 32. RIES S, STEINKE W, NEFF KW, HENNERICI M. Echocontrast-enhanced transcranial color-coded sonography for the diagnosis of transverse sinus venous thrombosis. Stroke 1997;28:696-700.
33. 33. BOGDAHN U, FRÖHLICH T, BECKER G et al. Vascularization of primary central nervous system tumors: detection with contrast-enhanced transcranial color-coded real-time sonography. Radiology 1994;192:141-8.
34. 34. YOUNG B, MOORE WS, ROBERTSON JT et al. An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. Stroke 1996;27:2216-24.
35. 35. SPENCER KT, BEDNARZ J, RAFTER PG, KORCARZ C, LANG RM. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol 1998;82:794-9.
36. 36. BURNS PN. Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology. J Neuroimaging 1997;7(suppl 1):S2-14.
37. 37. SEIDEL G, KAPS M. Harmonic imaging of the vertebrobasilar system. Stroke 1997;28:1610-13.
38. 38. ITOH T, MATSUMOTO M, UCHIMOTO R et al. Perfusion imaging of the brain by B-mode ultrasonography. An experimental study in rabbits. Stroke 1995;26:2353-6.
39. 39. KONO Y, MORIYASU F, NADA T et al. Gray scale second harmonic imaging of the liver: a preliminary animal study. Ultrasound Med Biol 1997;23:719-26.
40. 40. KONO Y, MORIYASU F, MINE Y et al. Gray-scale second harmonic imaging of the liver with galactose-based microbubbles. Invest Radiol 1997;32:120-5.
41. 41. PORTER TR, XIE F, Li S, D'SA A, RAFTER P. Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging. J Am Soc Echocardiogr 1996;9:599-605.
42. 42. VlLLARRAGA HR, FOLEY DA, AESCHBACHER BC, KLARICH KW, MULVAGH SL. Destruction of contrast microbubbles during ultrasound imaging at conventional power output. J Am Soc Echocardiogr 1997;10:783-91.
43. 43. PORTER TR, LI S, KRICSFELD D, ARMBRUSTER RW. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging. J Am Coll Cardiol 1997;29:791-9.
44. 44. MAIN ML, ESCOBAR JF, HALL SA, KILLAM AL, GRAYBURN PA. Detection of myocardial perfusion defects by contrast echocardiography in the setting of acute myocardial ischemia with residual antegrade flow. J Am Soc Echocardiogr 1998;11:228-35.
45. 45. COLON PJ, RICHARDS DR, MORENO CA, MURGO JP, CHEIRIF J. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging. J Am Soc Echocardiogr 1997;10:602-7.
46. 46. POSTERT T, MUHS A, MEVES S, FEDERLEIN J, PRZUNTEK H, BÜTTNER T. Transient response harmonic imaging: an ultrasound technique related to brain perfusion. Stroke 1998;29:1901-7.
47. 47. BURNS PN. Harmonic imaging with ultrasound contrast agents. Clinical Radiol 1996;51:50-5.
48. 48. BLOMLEY M, ALBRECHT T, COSGROVE D et al. Stimulated acoustic emission imaging ("sono-scintigraphy") with the ultrasound contrast agent Levovist: a reproducible Doppler ultrasound effect with potential clinical utility. Acad Radiol 1998;5(suppl 1):S236-9.
49. 49. BLOMLEY M, ALBRECHT T, COSGROVE D, JAYARAM V, BUTLER BARNES J, ECKERSLEY R. Stimulated acoustic emission in liver parenchyma with Levovist [letter]. Lancet 1997;351:568.
50. 50. HAUFF P, FRITZSCH T, REINHARDT M et al. Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 1997;32:94-9.
51. 51. KNIEMEYER HW, AULICH A, SCHLACHETZKI F, STEINMETZ H, SANDMANN W. Pseudo- and segmental occlusion of the internal carotid artery: a new classification, surgical treatment and results. Eur J Vasc Endovasc Surg 1996;12:310-20.
52. 52. STERPETTI AV, FELDHAUS RJ, SCHULTZ RD, FARINA C. Operative strategies in patients with symptomatic internal carotid artery occlusion. Surgery 1989;105:632-7.
53. 53. MEYER FB, SUNDT TM, Jr., PIEPGRAS DG, SANDOK BA, FORBES G. Emergency carotid endarterectomy for patients with acute carotid occlusion and profound neurological deficits. Ann Surg 1986;203:82-9.
54. 54. MCCORMICK PW, SPETZLER RF, BAILES JE, ZABRAMSKI JM, FREY JL. Thromboendarterectomy of the symptomatic occluded internal carotid artery. J Neurosurg 1992;76:752-8.
55. 55. The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-12.
56. 56. WARLOW C. Surgical treatment of asymptomatic carotid stenosis. Cerebrovasc Dis 1996;6(suppl 1):7-14.
57. 57. WARLOW CP, DENNIS MS, VANGIJN J et al. Stroke. A practical guide to management. Oxford, Blackwell Science, 1996.
58. 58. CHIMOWITZ MI, KOKKINOS J, STRONG J et al. The Warfarin Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488-93.
59. 59. HACKE W, KASTE M, FIESCHI C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25.
60. 60. The National Institute of Neurological Disorders and Stroke RT-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.